|
|
About
Medicines
Research
Responsibility
News
Investors
Careers
Exit Player
Loading the player ...
HIV / AIDS
Liver Diseases
Hematology / Oncology
Cardiovascular
Inflammation / Respiratory
Other Therapies
Gilead plays a central role in developing single tablet regimens – with one pill once a day, patients can take all of their medication in each dose.
Product Info
Pipeline Info
Our liver disease programs focus on expanding treatment options for chronic hepatitis B and C.
Product Info
Pipeline Info
Our scientists are applying new knowledge about how cancers grow and spread to potentially enhance and improve cancer therapy.
Product Info
Pipeline Info
Our medicines aim to help patients with cardiovascular disease return to their daily activities, and we are exploring potential new indications.
Product Info
Pipeline Info
We research and develop treatments for serious respiratory conditions such as influenza, cystic fibrosis and other diseases of the lungs.
Product Info
Pipeline Info
Gilead medicines treat severe fungal and parasitic infections, and address vision loss caused by degenerative eye diseases.
Product Info
Pipeline Info
Gilead Subsidiary to Launch Authorized Generics to Treat HCV
President and CEO John Milligan offers perspective on plans for authorized generic versions of its leading HCV medications. Read more 
here
.
Third Quarter 2018 Financial Results
Access earnings press release, webcast link and slides for Gilead’s third quarter 2018 financial results. 
View materials.
News
December 02, 2018
Kite Announces Two-Year Data for Yescarta® (Axicabtagene Ciloleucel) in Patients With Refractory Large B-Cell Lymphoma
About Gilead
Senior Management
Worldwide Operations
Ethics
Business Conduct
Business Partnerships
Corporate History Timeline
Research
Pipeline
Clinical Trials
Investigator Sponsored Research
Medicines
Request Information
Consumer Product Safety
Authorized Distributors of Record
Product Approval Timeline
Responsibility
U.S. Patient Access
Developing World Access
Corporate Contributions
Policy Perspectives
Gilead Foundation
News
Press Releases
Events
Media FAQs
Fact Sheets
Media Inquiries
Investors
Recent News
Corporate Governance
Stock Information
Financial Information
SEC Filings
Shareholder Center
Annual Reports
Email Alerts
Investor FAQs
Investor Contacts
Investor Disclaimer
Careers
Pipeline
Our Values
Developing-World-Access
Corporate-Contributions
U.S. Benefits
© 2009-2018 Gilead. All rights reserved. 
Terms of Use 
 |  
Privacy Statements
        Product images shown do not represent actual size.
    var switchTo5x = false;
    stLight.options({ publisher: "ur-8e0b5c0a-9b97-aaa4-f001-bc62ca9c441e" });